Bulk Manufacturer of Controlled Substances Application: Siegfried USA, LLC, 7129 [2019-03689]
Download as PDF
<![CDATA[
7129
Federal Register / Vol. 84, No. 41 / Friday, March 1, 2019 / Notices
with either or both of these definitions,
please explain why and provide
alternative definitions.
DEPARTMENT OF JUSTICE
Authority: This proceeding is being
conducted under authority of title VII of the
Tariff Act of 1930; this notice is published
pursuant to section 207.61 of the
Commission’s rules.
[Docket No. DEA–392]
By order of the Commission.
Issued: February 22, 2019.
Lisa Barton,
Secretary to the Commission.
ACTION:
Drug Enforcement Administration
Bulk Manufacturer of Controlled
Substances Application: Siegfried
USA, LLC
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before April 30, 2019.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
DATES:
[FR Doc. 2019–03452 Filed 2–28–19; 8:45 am]
BILLING CODE 7020–02–P
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on
November 5, 2018, Siegfried USA, LLC,
33 Industrial Park Road, Pennsville,
New Jersey 08070–3244 applied to be
registered as a bulk manufacturer of the
following basic classes of controlled
substances:
Controlled substance
Drug code
Gamma Hydroxybutyric Acid ...........................................................................................................................................
Dihydromorphine .............................................................................................................................................................
Hydromorphinol ...............................................................................................................................................................
Methylphenidate ..............................................................................................................................................................
Amobarbital ......................................................................................................................................................................
Pentobarbital ....................................................................................................................................................................
Secobarbital .....................................................................................................................................................................
Codeine ...........................................................................................................................................................................
Oxycodone .......................................................................................................................................................................
Hydromorphone ...............................................................................................................................................................
Hydrocodone ...................................................................................................................................................................
Methadone .......................................................................................................................................................................
Methadone intermediate ..................................................................................................................................................
Morphine ..........................................................................................................................................................................
Oripavine .........................................................................................................................................................................
Thebaine ..........................................................................................................................................................................
Opium tincture .................................................................................................................................................................
Oxymorphone ..................................................................................................................................................................
The company plans to manufacture
the listed controlled substances in bulk
for sale to its customers.
Dated: February 11, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019–03689 Filed 2–28–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
jbell on DSK30RV082PROD with NOTICES
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Meridian Medical
Technologies
ACTION:
Notice of application.
VerDate Sep<11>2014
18:13 Feb 28, 2019
Jkt 247001
Registered bulk manufacturers of
the affected basic class, and applicants
therefore, may file written comments on
or objections to the issuance of the
proposed registration on or before April
1, 2019. Such persons may also file a
written request for a hearing on the
application on or before April 1, 2019.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
DATES:
PO 00000
Frm 00114
Fmt 4703
Sfmt 4703
2010
9145
9301
1724
2125
2270
2315
9050
9143
9150
9193
9250
9254
9300
9330
9333
9630
9652
Schedule
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
E:\FR\FM\01MRN1.SGM
01MRN1
]]>Agencies
[Federal Register Volume 84, Number 41 (Friday, March 1, 2019)]
[Notices]
[Page 7129]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-03689]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Siegfried
USA, LLC
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before April 30, 2019.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on
November 5, 2018, Siegfried USA, LLC, 33 Industrial Park Road,
Pennsville, New Jersey 08070-3244 applied to be registered as a bulk
manufacturer of the following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid........... 2010 I
Dihydromorphine..................... 9145 I
Hydromorphinol...................... 9301 I
Methylphenidate..................... 1724 II
Amobarbital......................... 2125 II
Pentobarbital....................... 2270 II
Secobarbital........................ 2315 II
Codeine............................. 9050 II
Oxycodone........................... 9143 II
Hydromorphone....................... 9150 II
Hydrocodone......................... 9193 II
Methadone........................... 9250 II
Methadone intermediate.............. 9254 II
Morphine............................ 9300 II
Oripavine........................... 9330 II
Thebaine............................ 9333 II
Opium tincture...................... 9630 II
Oxymorphone......................... 9652 II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
in bulk for sale to its customers.
Dated: February 11, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-03689 Filed 2-28-19; 8:45 am]
BILLING CODE 4410-09-P
